COVID vaccines deployed in US highly effective at reducing hospitalizations and deaths

Researchers in the United States have conducted a large-scale study showing that the two-dose regimen vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) appear to be highly effective and durable in reducing the risk of hospitalizations and deaths following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Related Keywords

North Carolina ,United States ,China ,State Of North Carolina ,North Carolina State University ,Wuhan ,Hubei ,Sally Robertson ,Danyu Lin ,Pfizer ,Human Services ,Drug Administration ,Carolina Department Of Health ,Carolina State University ,Chapel Hill Gillings School ,Global Public Health ,North Carolina Department ,United States Over ,Surveillance Data ,Image Credit ,Coronavirus ,Coronavirus Disease Covid 19 ,Efficacy ,Health And Human Services ,Immunity ,Immunization ,Public Health ,Research ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Vaccine ,Virus ,